A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)
Source: Journal of Pain Research - Category: Anesthesiology Tags: Journal of Pain Research Source Type: research
More News: Anesthesiology | Cancer | Cancer & Oncology | Japan Health | Oxycodone | OxyContin | Pain | Study